New Clinical Trial to Transform Skin Cells into a Treatment for Parkinson's Disease
San Diego's Aspen Neuroscience gets federal go-ahead on therapy that does not require immune suppression
In a development that owes a debt to Mount Kilimanjaro, Aspen Neuroscience, Inc., announced today that it has received the go-ahead to begin a clinical trial for a stem cell treatment for Parkinson’s disease.
The trial sp…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.